Correlation Between BioNTech and ESGEN Acquisition

Can any of the company-specific risk be diversified away by investing in both BioNTech and ESGEN Acquisition at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioNTech and ESGEN Acquisition into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioNTech SE and ESGEN Acquisition Corp, you can compare the effects of market volatilities on BioNTech and ESGEN Acquisition and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioNTech with a short position of ESGEN Acquisition. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioNTech and ESGEN Acquisition.

Diversification Opportunities for BioNTech and ESGEN Acquisition

0.0

Correlation Coefficient

BioNTech  ESGEN Acquisition

Pay attention - limited upside

The 3 months correlation between BioNTech and ESGEN is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding BioNTech SE and ESGEN Acquisition Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESGEN Acquisition Corp and BioNTech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioNTech SE are associated (or correlated) with ESGEN Acquisition. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESGEN Acquisition Corp has no effect on the direction of BioNTech i.e., BioNTech and ESGEN Acquisition go up and down completely randomly.

Pair Corralation between BioNTech and ESGEN Acquisition

Given the investment horizon of 90 days BioNTech is expected to generate 5.6 times less return on investment than ESGEN Acquisition. In addition to that, BioNTech is 3.05 times more volatile than ESGEN Acquisition Corp. It trades about 0.0 of its total potential returns per unit of risk. ESGEN Acquisition Corp is currently generating about 0.07 per unit of volatility. If you would invest  1,030  in ESGEN Acquisition Corp on October 10, 2024 and sell it today you would earn a total of  71.00  from holding ESGEN Acquisition Corp or generate 6.89% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	26.01%
Values	Daily Returns

BioNTech SE  vs.  ESGEN Acquisition Corp

BioNTech SE

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in BioNTech SE are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, BioNTech may actually be approaching a critical reversion point that can send shares even higher in February 2025.

ESGEN Acquisition Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ESGEN Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, ESGEN Acquisition is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with BioNTech and ESGEN Acquisition

The main advantage of trading using opposite BioNTech and ESGEN Acquisition positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioNTech position performs unexpectedly, ESGEN Acquisition can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESGEN Acquisition will offset losses from the drop in ESGEN Acquisition's long position.

The idea behind BioNTech SE and ESGEN Acquisition Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.